Through a CPRIT Prevention award, UT Health Science Center at San Antonio is bringing genetic counseling and testing services to areas of Texas never before reached.
With a CPRIT Research award, Texas Tech University Health Science Center at El Paso is helping patients access cutting-edge clinical trials.
Cancer is the leading cause of death for Asian Americans. With a prevention grant from CPRIT, Light & Salt Association is working to equip communities with education and access to screening that can save lives.
With a research grant from CPRIT, scientists at the University of Texas Health Science Center at San Antonio are studying risk factors associated with increased liver cancer rates in South Texas.
Through a CPRIT Prevention award, health educators at Centro San Vicente of El Paso are empowering patients to take charge of their cancer screening needs.
Motivated by his experience as a pediatric brain tumor survivor, CPRIT Scholar Dr. Ryan Potts studies the biochemical and molecular mechanisms behind cancer cell formation.
Adolescent and young adult (AYA) cancer survivors participating in Seton Healthcare Family's ACCESS-AYA grant from CPRIT. The grant educates survivors and providers about the unique needs of AYAs.
Scientists at the University of Texas at El Paso are developing a novel therapy to treat both early and late stage prostate cancer.
Dr. Conrad Lyford of Texas Tech University discusses a unique public-private partnership made possible by a CPRIT Prevention award to promote cancer prevention in rural communities.
Dr. DeBerardinis of UT Southwestern Medical Center shares how a CPRIT Research award has lead to discovery of unique metabolic pathways that enable tumor growth.
Dr. Susan Campbell of the Cooper Institute discusses how a CPRIT Prevention award is empowering health care professionals, the public, and communities to fight obesity and reduce cancer risk.
19-year-old James Ragan is a student at Rice University, golfer, and founder of Triumph Over Kid Cancer Foundation. James is currently battling osteosarcoma, a type of cancer that starts in the bones, typically during adolescence.
Professor of Radiology at UT Southwestern Medical Center and CPRIT Research Award Recipient discusses the role of imaging to evaluate the effectiveness of a new cancer treatment.
CPRIT grantee Dr. Kevin Pinney at Baylor University describes his work with anticancer agents and their possible effect on tumor blood vessels.
Texas A&M's Dr. David McLellan describes his CPRIT-funded work in educating the uninsured and underserved residents of Brazos County about risks of colon cancer, as well as medical training for colonoscopies.
Dr. Ray DuBois, Provost and Executive Vice President at MD Anderson Cancer Center and CPRIT grantees, describes how CPRIT funds are being used in colon cancer research.
CPRIT grantee Julie St. John of Texas A&M University Health Science Center describes a prevention project using promotoras, or community health workers, along the Texas-Mexico border.
Dr. Deborah Parra-Medina explains a peer education and outreach program to prevent cervical cancer among Latina mothers and daughters living in Texas-Mexico border communities.
University of Texas Grantee George Georgiou describes his work starving cancer cells of essential nutrients, thus causing them to die.
Cynthia Mojica describes Salud San Antonio!, a CPRIT-funded prevention program using promotoras performing outreach and education among Latinas about breast, cervical and colorectal cancers.
CPRIT Grantee Dr. Jim Brugolas of UT Southwestern describes his research into the progression of cell development in the area of kidney cancer.
Martha Martinez of Mercy Ministries of Laredo describes how a CPRIT Prevention Grant will provide outreach and education services to underserved communities in Laredo and surrounding counties.
Dr. Yongcheng Song, Assistant Professor at Baylor College of Medicine, describes his work targeting a very aggressive type of leukemia which primarily affects children and has a very low survival rate.
Haley Justice-Gardiner of LIVESTRONG explains how a CPRIT Prevention Grant will increase awareness, access, and utilization of survivorship resources among Hispanic/Latino cancer survivors
Dr. Larry Kwak, CPRIT Grantee from The University of Texas M.D. Anderson Cancer Center, discusses the progress of a personalized DNA vaccine that targets lymphoma.
Dr. Maria Jibaja-Weiss of Baylor College of Medicine explains how a CPRIT Prevention Grant will assist medically underserved patients in Harris County.
Dr. Lidong Qin, CPRIT Scholar at Methodist Hospital in Houston, discusses research which helps determine the disease stage of prostate cancer and ultimately leads to better treatment.
As chair of CPRIT’s Prevention Review Council, Dr. Wyatt oversees the selection of the agency’s prevention grants.
Dr. Ralf Kittler, CPRIT Scholar in Cancer Research, discusses the progress of his research lab at The University of Texas Southwestern Medical School and the critical importance of his studies in the area of early detection of cancer.
Dr. Samir Gupta of UT Southwestern Medical Center is working with John Peter Smith Hospital Health System to increase colorectal cancer screening for underserved Texans in the Fort Worth area.
Learn more about Dr. David Tweardy’s efforts to develop more specific, targeted drugs for cancer at The Baylor College of Medicine.
Paul Lammers, President and CEO of Mirna Therapeutics, discusses the impact of CPRIT Funding on the company's ongoing work to develop synthetic microRNAs as therapeutic agents. These newly discovered regulatory molecules have profound effects on cell development and can hopefully be used to inhibit cancer development or growth.
Patricia Stoll is a cancer patient who has benefitted greatly from The Rose, a Houston-based CPRIT Grantee. “The funding from The Rose probably saved my life,” explains Stoll.
Dr. Jeffrey M. Rosen, Ph.D., is the C.C. Bell Professor of Molecular and Cellular Biology at Baylor College of Medicine. He talks about how cancer has touched his life, his history in cancer research and how the CPRIT grants are helping to train the next generation of cancer researchers.
Craig Benson, President and CEO of Rules-Based Medicine, talks about how the CPRIT funds will allow his company to expand their capability and in doing so, enable researchers to take a more detailed look at the impact of cancer than ever before.
Dr. Keith Argenbright of The Moncrief Cancer Institute: CPRIT Prevention Dollars at work!
Dr. Bert O’Malley is chair and professor of molecular and cellular biology at Baylor College of Medicine. His primary research focus is on hormone action and gene expression: coactivators and corepressors.
Dorothy Gibbons speaks about her organization and how a CPRIT prevention award is making a difference in her community.
Consider attending CPRIT’s inaugural Innovations in Cancer Prevention and Research Conference from November 17th through 19th in Austin, Texas.
CPRIT's annual finance webinar.
Bill Gimson welcomes you, the people of Texas, to our new website!
Dr. Al Gilman talks about the Research effort at CPRIT and the types of projects they look for.
Dr. Becky Garcia tells us what the prevention department is looking for at CPRIT.
Jerry Cobbs talks about the Commericialization effort at CPRIT.
Annette Leslie is the mother of Carson Leslie. Carson passed away January 12, 2010 at the age of 17 from medulloblastoma, brain and spine cancer. Annette is making a difference by carrying on in the fight against pediatric cancer by making speeches, publishing Carson's book, Carry Me, and by being a member on our Advisory Committee on Child Cancer.